scholarly journals Central Nervous System Toxoplasmosis in Relapsed Hodgkin’s Lymphoma: A Case Report

2016 ◽  
Vol 9 (4) ◽  
Author(s):  
Hassan Abolghasemi ◽  
Ehsan Shahverdi ◽  
Ramezan Jafari ◽  
Fardin Dolatimehr ◽  
Azam Khandani
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma

Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literature

2000 ◽  
Vol 99 (6) ◽  
pp. 709-714 ◽  
Author(s):  
U. Herrlinger ◽  
K. Klingel ◽  
R. Meyermann ◽  
R. Kandolf ◽  
E. Kaiserling ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Review Of The Literature ◽  
Systemic Manifestation

scholarly journals Multicentric Involvement of Non-Hodgkin's Lymphoma in the Central Nervous System and Testis-Case Report-

2004 ◽  
Vol 44 (9) ◽  
pp. 493-496
Author(s):  
Kenichiro ONO ◽  
Hirohiko ARIMOTO ◽  
Kojiro WADA ◽  
Takashi TAKAHARA ◽  
Toshiki SHIROTANI ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System

scholarly journals Primary central nervous system Hodgkin's lymphoma: a case report

2021 ◽  
Vol 49 (4) ◽  
pp. 030006052199953
Author(s):  
Haiying Fu ◽  
Songsheng Shi ◽  
Lusan Chen ◽  
Benhua Xu ◽  
Wanling Huang ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Hodgkin’S Lymphoma ◽  
Full Range ◽  
External Ventricular Drainage ◽  
Hodgkin's Lymphoma ◽  
Current Case ◽  
Left Lower Extremity ◽  
The Right

Primary central nervous system Hodgkin's lymphoma (CNS-HL) is extremely rare. This current case report describes a 60-year-old male patient that presented with numbness of the left lower extremity and worsening headache. After a full range of investigations and a partial resection of the right cerebellum, external ventricular drainage reservoir placement and cranioplasty, he was diagnosed with primary CNS-HL. The patient was treated with 3 g/m2 methotrexate (intravenous [i.v.], once a day, day 1) and 1 g/m2 cytarabine (i.v., every 12 h, days 2 + 3), followed by anti-programmed cell death protein 1 antibodies (200 mg sintilimab, i.v., once a day, day 1, every 3 weeks). After six courses of treatment with intrathecal injections of 50 mg cytarabine (once a day, day 1) and 5 mg dexamethasone (once a day, day 1), there was no residual lesion on cranial magnetic resonance imaging. No significant drug-related adverse events were observed. The patient has been followed up every 3 months and no relapse has occurred.

Sign in / Sign up

Export Citation Format

Share Document